Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Urol. Nov 24, 2014; 3(3): 152-160
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.152
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.152
Non-pharmacologic options for the management of voiding dysfunction in multiple sclerosis
Lisa Parrillo, Eliza Lamin, Ariana Smith, Perelman Center for Advanced Medicine, West Pavilion, Philadelphia, PA 19104, United States
Author contributions: Parrillo L, Lamin E and Smith A contributed to this paper.
Correspondence to: Ariana Smith, MD, Perelman Center for Advanced Medicine, West Pavilion, 3rd Floor, 3400 Civic Center Boulevard, Philadelphia, PA 19104, United States. ariana.smith@uphs.upenn.edu
Telephone: +1-215-6622891
Received: April 14, 2014
Revised: July 3, 2014
Accepted: July 25, 2014
Published online: November 24, 2014
Processing time: 219 Days and 17.4 Hours
Revised: July 3, 2014
Accepted: July 25, 2014
Published online: November 24, 2014
Processing time: 219 Days and 17.4 Hours
Core Tip
Core tip: Patients with multiple sclerosis can present with a variety of different urologic symptoms. While they can be treated with multiple pharmacologic agents, at times they will require manipulation or surgical intervention. This article reviews the scientific evidence behind each treatment modality so providers may be more informed as they council patients.